Answers are grounded in this paper and cite their sources.
Jugular foramen schwannoma surgery during pregnancy requires decisions that integrate tumor anatomy, cranial nerve function, maternal physiology and fetal observations. Concurrent changes in these measurements can influence resection, but a single case cannot establish their mechanism or validate a stopping threshold. A 27-year-old woman, gravida 2 para 1, presented at 22 weeks of gestation with progressive posterior fossa symptoms, grade III papilledema and a 45 × 35 × 52-mm left cerebellopontine angle–dominant schwannoma extending into the jugular foramen region. Left retrosigmoid maximal safe decompression was undertaken. During manipulation near the jugular foramen entrance, two episodes of evoked laryngeal electromyographic deterioration coincided with maternal heart-rate decreases. The first resolved after manipulation was paused, without a recorded blood-pressure or fetal heart-rate change. During the second, maternal heart rate decreased to 54–56 beats/min and blood pressure to 90/60 mmHg. Pausing manipulation alone was insufficient for maternal recovery. A fetal heart-rate decrease to 100–105 beats/min was recorded during the pause, prompting ephedrine and atropine administration before subsequent maternal hemodynamic recovery. Further dissection toward the foraminal component was stopped. Magnetic resonance imaging on postoperative day 2 showed a residual measuring 18 × 22 × 17 mm; the radiologist reported dimensions of 20 × 23 × 17 mm on follow-up imaging approximately one month before delivery. No new deficit was identified on clinical neurological examination, and the patient was discharged on postoperative day 7. Delivery occurred by cesarean section at 39 weeks and 1 day. Birth weight was 3650 g, the 5-minute Apgar score was 9, and maternal Karnofsky Performance Status was 90 on postpartum day 3. This case illustrates how concurrent intraoperative monitoring changes contributed to an individualized decision to limit resection during pregnancy. The observations describe reported temporal concurrence, not a proven vagal mechanism or fetal hypoperfusion. Incomplete synchronized monitoring data and limited objective functional and tumor follow-up preclude generalizable safety or stopping-threshold claims.
No takes yet. Share an insight, caveat, or question.
Yoldoshev et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: